Form 8-K Coherus BioSciences, For: Sep 08
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Arm Holdings falls as CFO stock sale weighs on sentiment
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
Coherus BioSciences (CHRS) Increases ATM Offering Program by $28.75M
September 12, 2023 6:14 AM EDTOn May 15, 2023, Coherus BioSciences (NASDAQ: CHRS) previously announced that it reduced the amount of shares that could be issued and sold pursuant to its at-the-market program (ATM) with Cowen and Company, LLC (TD Cowen) in an amount equal to $86.25 million. The reduction in the amount... More
